We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAF
7101
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$6K ﹤0.01%
2
CSTR
7102
DELISTED
CapStar Financial Holdings, Inc
CSTR
$6K ﹤0.01%
287
-1,599
-85% -$28.2K
ITCL
7103
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$6K ﹤0.01%
441
-1,006
-70% -$14.2K
LOV
7104
DELISTED
Spark Networks SE American Depositary Shares
LOV
$6K ﹤0.01%
5,085
-17,943
-78% -$19.2K
JNCE
7105
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$6K ﹤0.01%
+364
New +$5.15K
HTGM
7106
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$6K ﹤0.01%
20
+14
+233% +$5.32K
PZN
7107
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$6K ﹤0.01%
+558
New +$5.7K
TRIL
7108
DELISTED
Trillium Therapeutics Inc.
TRIL
$6K ﹤0.01%
+1,230
New +$5.78K
FORK
7109
DELISTED
Fuling Global Inc
FORK
$6K ﹤0.01%
991
-2,016
-67% -$7.38K
VSLR
7110
DELISTED
VIVINT SOLAR, INC.
VSLR
$6K ﹤0.01%
1,840
-17,359
-90% -$84K
SCIJ
7111
DELISTED
Global X Scientific Beta Japan ETF
SCIJ
$6K ﹤0.01%
+200
New +$5.97K
AGFSW
7112
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$6K ﹤0.01%
10,000
ENT
7113
DELISTED
Global Eagle Entertainment Inc.
ENT
$6K ﹤0.01%
+65
New +$5.09K
RARX
7114
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$6K ﹤0.01%
393
-65,241
-99% -$986K
GNMX
7115
DELISTED
Aevi Genomic Medicine Inc
GNMX
$6K ﹤0.01%
4,843
+2,799
+137% +$3.58K
BORN
7116
DELISTED
China New Borun Corporation
BORN
$6K ﹤0.01%
4,250
+654
+18% +$842
PLND
7117
DELISTED
VanEck Vectors Poland ETF
PLND
$6K ﹤0.01%
285
-2,127
-88% -$42.2K
NXEO
7118
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$6K ﹤0.01%
855
-310
-27% -$2.37K
C.WS.A
7119
DELISTED
Citigroup Inc
C.WS.A
$6K ﹤0.01%
59,543
-3,458
-5% -$473
SHLDW
7120
DELISTED
Sears Holdings Corporation - Warrant
SHLDW
$6K ﹤0.01%
3,143
-2,274
-42% -$5.12K
XIVH
7121
DELISTED
VelocityShares VIX Short Volatility Hedged ETN
XIVH
$6K ﹤0.01%
100
-1,969
-95% -$111K
CGNT
7122
DELISTED
Cogentix Medical, Inc.
CGNT
$6K ﹤0.01%
2,427
-4,156
-63% -$9.11K
STLY
7123
DELISTED
Stanley Furniture Co Inc
STLY
$6K ﹤0.01%
+4,900
New +$5.82K
SLNOW
7124
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
$6K ﹤0.01%
10,418
+8,559
+460% +$4.99K
RNVA
7125
DELISTED
Rennova Health, Inc.
RNVA
$6K ﹤0.01%
2,218
+596
+37% +$2.55K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.